GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » File Forge Technology PLC (AQSE:FILE) » Definitions » Asset Impairment Charge

File Forge Technology (AQSE:FILE) Asset Impairment Charge : £0.00 Mil (TTM As of . 20)


View and export this data going back to 2021. Start your Free Trial

What is File Forge Technology Asset Impairment Charge?

File Forge Technology's Asset Impairment Charge for the six months ended in . 20 was £0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.


File Forge Technology Asset Impairment Charge Historical Data

The historical data trend for File Forge Technology's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

File Forge Technology Asset Impairment Charge Chart

File Forge Technology Annual Data
Trend
Asset Impairment Charge

File Forge Technology Semi-Annual Data
Asset Impairment Charge

File Forge Technology Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Asset Impairment Charge for the trailing twelve months (TTM) ended in . 20 was £0.00 Mil.


File Forge Technology Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of File Forge Technology's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.


File Forge Technology (AQSE:FILE) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
16 Great Queen Street, 9th Floor, London, GBR, WC2B 5DG
Clarify Pharma PLC is engaged in performing research or producing neuro-pharmaceutical drug development platforms that advance medicines through science and clinical trials. Its mission is to nurture the scientific advancement of mental, emotional, psychological, and physical health by investing in alternative therapies, modalities, and sciences.

File Forge Technology (AQSE:FILE) Headlines

No Headlines